DSC Advisors’s Allergan plc AGN Stock Holding History

DSC Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20,000	Closed	-$3.37M	–	105
2019 Q3	$3.37M	Hold	20,000	–	–	0.67%	22
2019 Q2	$3.35M	Buy	+20,000	New	+$2.77M	0.59%	24

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

DSC Advisors's AGN Position: Q4 2019 in Review

DSC Advisors sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 20,000 shares — an estimated $3.37M sold.

DSC Advisors first reported a position in AGN in Q2 2019 and held it in 2 quarters. The position peaked at $3.37M in Q3 2019. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

DSC Advisors reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
DSC Advisors sold 20,000 Allergan plc shares in Q4 2019, an estimated $3.37M.
DSC Advisors first reported a position in Allergan plc in Q2 2019 and held it in 2 quarters.
DSC Advisors's Allergan plc position peaked at $3.37M in Q3 2019.
957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on DSC Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.